Home › Funds › THOMPSON DAVIS & CO., INC. › PROF

THOMPSON DAVIS & CO., INC. position in PROF

PROFOUND MED CORP · Health Care

THOMPSON DAVIS & CO., INC. reported holding 239,118 shares of PROF (PROFOUND MED CORP) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 0.93% of its reported portfolio and ranking #16 among its reported holdings. THOMPSON DAVIS & CO., INC. has disclosed PROF holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)239.12K sh
Reported value held$1.39M
Portfolio Weight0.93%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How THOMPSON DAVIS & CO., INC.'s PROF position evolved

THOMPSON DAVIS & CO., INC. first disclosed a stake in PROF in Q3 2023 at 86,375 shares (US$881K). The position peaked in Q4 2025 at 216,735 shares, worth US$1.7M. Across 13 filings, THOMPSON DAVIS & CO., INC. increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 239,118 shares valued at US$1.4M — an increase of 22,583 shares quarter over quarter.. Notable position changes include a 36% increase in Q3 2024 (shares fell 6% over the following quarter), a 79% increase in Q4 2024 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 86.38K $881.02K New
Q4 2023 68.42K $580.93K Reduce
Q1 2024 68.65K $585.59K Hold
Q2 2024 74.80K $627.57K Add
Q3 2024 101.90K $811.12K Add
Q4 2024 182.29K $1.37M Add
Q1 2025 203.85K $1.19M Add
Q2 2025 210.50K $1.24M Add
Q3 2025 208.72K $1.02M Reduce
Q4 2025 216.74K $1.71M Add
Q1 2026 215.78K $1.40M Hold
Q2 2026 216.53K $1.44M Hold
Q3 2026 239.12K $1.39M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PROF and 13F data

PROF (PROFOUND MED CORP) is a Health Care company. 30 other funds we track also report a position in PROF — the largest reported positions include GAGNON SECURITIES LLC (US$11.9M), Timelo Investment Management Inc. (US$7.4M), Gagnon Advisors, LLC (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PROF

All PROF fund holders →

FAQ

How long has THOMPSON DAVIS & CO., INC. held PROF?

THOMPSON DAVIS & CO., INC. has disclosed PROF holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is THOMPSON DAVIS & CO., INC.'s current position in PROF?

As of Q3 2026, THOMPSON DAVIS & CO., INC. holds 239.12K shares of PROF (PROFOUND MED CORP), valued at $1.39M, representing 0.93% of its reported portfolio and ranking #16.

Has THOMPSON DAVIS & CO., INC. been buying or selling PROF?

In the latest 13F filing (Q3 2026), THOMPSON DAVIS & CO., INC. increased its position in PROF. The position peaked in Q4 2025 at 216.74K shares.

Which other funds hold PROF?

Other major institutional holders of PROF include GAGNON SECURITIES LLC, Timelo Investment Management Inc., Gagnon Advisors, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.